Advertisement
UK markets close in 3 hours 53 minutes
  • FTSE 100

    8,216.23
    +60.51 (+0.74%)
     
  • FTSE 250

    21,182.20
    +114.52 (+0.54%)
     
  • AIM

    785.10
    +0.97 (+0.12%)
     
  • GBP/EUR

    1.1881
    +0.0015 (+0.12%)
     
  • GBP/USD

    1.2937
    +0.0027 (+0.21%)
     
  • Bitcoin GBP

    52,137.82
    +467.57 (+0.90%)
     
  • CMC Crypto 200

    1,387.59
    -17.74 (-1.26%)
     
  • S&P 500

    5,505.00
    -39.59 (-0.71%)
     
  • DOW

    40,287.53
    -377.47 (-0.93%)
     
  • CRUDE OIL

    79.72
    -0.41 (-0.51%)
     
  • GOLD FUTURES

    2,404.60
    +5.50 (+0.23%)
     
  • NIKKEI 225

    39,599.00
    -464.79 (-1.16%)
     
  • HANG SENG

    17,635.88
    +218.20 (+1.25%)
     
  • DAX

    18,401.78
    +229.85 (+1.26%)
     
  • CAC 40

    7,627.95
    +93.43 (+1.24%)
     

Senseonics Holdings, Inc. to Participate in the Gilmartin Group Emerging Growth Company Showcase

GERMANTOWN, Md., September 14, 2023--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Gilmartin Group Emerging Growth Company Showcase, taking place virtually.

Management is scheduled to present on Thursday, September 21, 2023 from 11:30 a.m. to 11:55 a.m. ET. Interested parties may access a live and recorded webcast of the presentation on the "Investor Relations" section of the company’s website at www.senseonics.com.

About Senseonics

Senseonics Holdings, Inc. ("Senseonics") is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems, Eversense®, Eversense® XL and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230914484852/en/

Contacts

Investor Contact
Philip Taylor
Gilmartin Group
415-937-5406
Investors@senseonics.com